Evidence map›Paper›PMID 9351713›Full record

ArticleAnnals of surgery1997

Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection.

A Lyons, J L Kelly, M L Rodrick, J A Mannick, J A Lederer

Open access · greenAbstract read
In one paragraph

Article in Annals of surgery, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 216 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Innate Immune System Response to Burn Damage-Focus on Cytokine Alteration.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Article
  10. Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis.American journal of physiology. Gastrointestinal and liver physiology · 2016
    Article
  11. Article
  12. Article
  13. Article
  14. Anti-Inflammatory Effect of Taurine in Burned Patients.Advanced pharmaceutical bulletin · 2015
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. The effect of levamisole on mortality rate among patients with severe burn injuries.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
    Article
  20. Immunomodulation in transfused trauma patients.Current opinion in anaesthesiology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

A LyonsDepartment of Surgery, Harvard Medical School/Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
J L Kelly
M L Rodrick
J A Mannick
J A Lederer
Harvard University · USBrigham and Women's Hospital · US

Funding

IMMUNOLOGIC STUDIES OF PATIENTS AFTER TRAUMATIC INJURYR01GM035633 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI LEDERER, JAMES A. · 1985 to 2010
$3.3M
NIGMS NIH HHS GM35633
6 · The paper itself

Abstract

objectiveThe purpose of this study was to compare the production of interleukin-10 (IL-10) by peripheral blood mononuclear cells (PBMC) from injured patients and control subjects to determine the responsible cell types and to relate IL-10 production to the occurrence of sepsis. A mouse model of burn injury was used to confirm the human findings and to assess the importance of IL-10 in the lowered resistance to infection after injury. SUMMARY BACKGROUND DATA: Severe injury is associated with depressed immune responses. Although IL-10 is known to inhibit several aspects of immune reactivity, the role of IL-10 in postinjury immune suppression remains controversial.

methodsPeripheral blood mononuclear cells from 14 burn and 12 trauma patients and 16 healthy individuals were studied at serial intervals for IL-10 production stimulated by a T-cell mitogen, phytohemagglutinin, and by bacterial lipopolysaccharide. To determine the source of IL-10, CD4+ and CD8+ lymphocyte subsets were obtained by selective depletion of PBMC with antibody-coated magnetic beads and were stimulated by anti-CD3 antibody to induce IL-10 secretion. In addition, IL-10 production by patients' PBMC in the first 10 days after injury was assessed for correlation with subsequent septic events. Anti-CD3-stimulated IL-10 production also was determined for CD4- and CD8-enriched lymphocyte subsets obtained by antibody and complement depletion of splenocytes harvested from groups of burn and sham burn mice at day 10 after injury, the time of maximal susceptibility to a septic challenge, cecal ligation and puncture (CLP). Finally, to test the importance of IL-10 in immune suppression in vivo, groups of burn and sham burn mice were treated with anti-IL-10 monoclonal antibody or control immunoglobulin G (IgG) on days 1 and 3 postinjury and were observed for survival after CLP on day 10.

resultsPatients' PBMC produced significantly more IL-10 than did controls' PBMC 7 to 14 days after injury. Patients' CD4+ (T-helper) but not CD8+ (T-cytotoxic) lymphocytes also showed increased IL-10 production versus those of control subjects early after injury. Increased PBMC IL-10 production in the first 10 days postinjury correlated significantly (p < 0.05) with subsequent septic events. Burn mouse CD4-enriched but not CD8-enriched splenocytes produced more IL-10 than did sham burn splenocyte subsets on day 10 after injury. Burn mice treated with anti-IL-10 antibody but not with control IgG had significantly increased survival after CLP.

conclusionSerious injury in humans and in a mouse burn model is followed by increased stimulated production of IL-10 by cells of the immune system. The CD4+ T-helper cells appear to be a major source of IL-10 after injury. In injured patients, increased IL-10 production is correlated with subsequent septic events, and in the burn mouse, IL-10 appears to induce decreased resistance to infection.

Indexed as

Lymphocyte ActivationAdultAnimalsBurnsCecumDisease Models, AnimalFemaleHumansInfectionsInjury Severity ScoreInterferon-gammaInterleukin-10Interleukin-2Leukocytes, MononuclearLigationLipopolysaccharidesInterferon-gammaInterleukin-10Interleukin-2LipopolysaccharidesPhytohemagglutinins

Identifiers

PMID9351713
PMCPMC1191059
OpenAlexW2080880272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.